| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Total other income (expenses) | 65,355 | 74,655 | 75,818 | 123,767 |
| Net (loss) before income taxes | -1,021,258 | -1,980,000 | -1,219,932 | -982,586 |
| Provision for income taxes | -137,438 | -209,166 | -40,161 | 215,217 |
| Net (loss) | -883,820 | -1,770,834 | -1,179,771 | -1,197,803 |
| Gain (loss) from foreign exchange translation | -601,628 | 1,084,557 | - | 851,640 |
| Comprehensive (loss) | -1,485,448 | -686,277 | - | -346,163 |
| Earnings per share, diluted | - | -0.82 | -0.44 | - |
| Weighted average number of shares outstanding, diluted | - | 3,604,653 | 2,703,293 | 1,267,565 |
| Basic (loss) per common share | -0.19 | -0.39 | -0.44 | -0.94 |
| Weighted average common shares outstanding (basic) | 4,555,945 | 4,496,108 | 2,703,293 | 1,267,565 |
Sunshine Biopharma Inc. (SBFM)
Sunshine Biopharma Inc. (SBFM)